Daily Insulin Dose Tied to Cancer Risk in Patients With Type 1 Diabetes
Daily insulin dose linked to cancer risk in multivariable model, with increasing cancer incidence in low-, medium-, high-dose insulin groups.
Diabetes
Effect of Keto and Mediterranean Diets on Glucose Control Compared
Limiting added sugar and refined grains helpful, but no added overall health benefit seen for cutting out legumes, fruits, and whole grains.
FDA Clears PENS Device for Pain Related to Diabetic Peripheral Neuropathy
First Relief is a wearable PENS device that is placed behind the ear.
California Will Produce Its Own Insulin to Bring Down Prices
As part of California’s new budget, $50 million will go directly to the development of low-cost insulin products to increase access for patients with diabetes.
Senate Introduces Bill Aimed at Lowering Insulin Prices
A bipartisan bill was introduced to the Senate to reduce the soaring price of insulin for patients on both Medicare and private insurance plans.
Efficacy of GLP-1 Agonists for Weight Loss in Adults Without Diabetes
Author reviews the pathophysiology of obesity including the role of incretin hormones and the mechanism of action, efficacy, and safety of GLP-1 receptor agonists as antiobesity medications.
Endocrine Society Issues New Guidelines for Hospitalized Patients With Diabetes
New guidelines for hospitalized patients with diabetes emphasize goal-directed glycemic management, continuous glucose monitoring, and use of insulin pumps to improve outcomes and reduce the likelihood of readmission.
Obesity in Adolescence Linked to Type 1 Diabetes in Adulthood
Adolescent obesity is correlated with both adult-onset type 1 diabetes and type 2 diabetes.
Metformin, Lifestyle Changes Cut Risk for T2DM, But Not CVD
No reduction seen in first occurrence of nonfatal MI, stroke, or CV death with either metformin or lifestyle intervention vs placebo.
Risk for Hospitalization for Heart Failure Down With SGLT-2i Treatment for T2D
Researchers conducted a population-based cohort study involving patients with T2D aged 18 years and older initiating treatment with SGLT-2i or metformin.
- Loading...
Loading...
Next post in Cardiovascular Disease Information Center
Loading... 
Loading...